EyePoint Pharmaceuticals, Inc. (EYPT) compared with its closest peers (RVTY, AVTR, BRKR, TXG, BIO). Peer set by Business model: Medical Devices / Life Science Tools; 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Revvity, Inc. (RVTY) | $13.85B | 77.0 |
| Avantor, Inc. (AVTR) | $9.73B | -14.7 |
| Bruker Corporation (BRKR) | $9.13B | -314.1 |
| 10x Genomics, Inc. (TXG) | $8.16B | -46.6 |
| BIO-RAD LABORATORIES, INC. (BIO) | $8.00B | — |
| Alamar Biosciences, Inc. (ALMR) | $2.40B | — |
| Cytek Biosciences, Inc. (CTKB) | $605.07M | -9.7 |
| Pacific Biosciences of California, Inc. (PACB) | $380.77M | -1.0 |
| Harvard Bioscience, Inc. (HBIO) | $159.48M | -0.5 |
| Quanterix Corporation (QTRX) | $147.55M | -2.5 |
| Sector P/E (Technology) | 33.9 |
| Industry P/E (Measuring & Control Equipment) | 51.8 |
EYPT overview · EYPT earnings · EYPT financials · EYPT KPIs · EYPT investor relations · EYPT ownership · EYPT filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.